MedPath

Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing

Not Applicable
Active, not recruiting
Conditions
Respiratory Disease
COVID-19
Interventions
Other: Breathing techniques over 12 sessions / 6 weeks inc yoga
Registration Number
NCT05732571
Lead Sponsor
University of Nottingham
Brief Summary

A pilot Study

To investigate the efficacy of a breathing intervention for improving persistent breathlessness due to dysregulated breathing following COVID-19 when compared to usual care.

Detailed Description

Pilot RCT for upto 60 subjects across 2 arms

Intervention A 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants.

Each online session will be circa 40-50 minutes in length. This will include an Introduction and warm up; Breathing practice including yogic breathing and a final cool down and relaxation.

Sessions will run at set times to ensure efficient use of resources but will try to accommodate different time points periods of the day when patients might be functioning best.

Comparator A six week non-intervention (usual care) period will be recruited to, allowing a comparison to the intervention.

Primary co-outcomes

Change in

* Breathlessness: Chronic Respiratory Disease Questionnaire-Dyspnoea domain (CRQ-D)

* Functional measure: 5 repetition chair to stand (5RCTS)

Secondary measures include other measures of breathlessness, function, adherence and completion (see full text for detail).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Either hospitalised or non-hospitalised with confirmed COVID-19 acute infection.
  • Received a comprehensive clinical respiratory assessment
  • Persisting (>12 weeks) self-reported breathlessness (on CRQ-D) following COVID-19 and confirmed dysregulated breathing (Nijmegen Questionnaire score NQ >23)
  • Age 18 - 80 years of age
  • Ability to give informed consent
  • Able to understand and speak English language
Exclusion Criteria
  • Severe mood disturbance that limits engagement with the intervention and study outcomes
  • No access to online delivery and/or IT illiterate
  • Significant diagnosed Myalgic Encephalitis/Fibromyalgia/Chronic Fatigue Syndrome prior to developing COVID-19
  • Severe asthma or other chronic lung disease prior to COVID-19

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Breathing Techniques InterventionBreathing techniques over 12 sessions / 6 weeks inc yogaA 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants.
Primary Outcome Measures
NameTimeMethod
Breathlessness.7 weeks

Chronic Respiratory Disease Questionnaire - Dyspnoea Domain Range 1-7 with lower - worse

Function7 weeks

5 repetition chair to stand. Range 0-120 seconds with longer worse

Secondary Outcome Measures
NameTimeMethod
Chalder Fatigue Score7 weeks

Questionnaire. Range 0-33. Greater worse

Borg Scale of Breathlessness7 weeks

Measure of breathlessness. Range 0-10. Greater worse

Capnography - in some volunteers7 weeks

End tidal CO2 measure in breath - at rest. Range N/A

Dyspnoea-12 Questionnaire7 weeks

SOB questionnaire. Range 0-36, Greater, worse

Modified Minnesota Physical Activity7 weeks

Questionnaire. Range 0-100. Greater better.

Four metre Gait speed7 weeks

field test of physical performance. Range 0-60seconds. Greater worse

EQ5D Quality of Life score7 weeks

Questionnaire. VAS 0-100. Greater is better.

Adherence7 weeks

Recorded from number of potential sessions. Range 0-12. Greater better.

Breath hold, Respiratory rate7 weeks

Observational measures at rest. Breath hold - 0-45. Greater better. RR. Range 0-30. Greater worse

Nijmegen Questionnaire7 weeks

Measure of dysregulated breathing. 0-64. Greater worse

Trial Locations

Locations (1)

Nottingham University Hospitals Trust

🇬🇧

Nottingham, Notts, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath